Literature DB >> 12119229

The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.

Andrew G Nicholson1, Laura G Fulford, Thomas V Colby, Roland M du Bois, David M Hansell, Athol U Wells.   

Abstract

We have retrospectively studied 53 patients with idiopathic pulmonary fibrosis and a histologic diagnosis of usual interstitial pneumonia and evaluated the prognostic significance of four individual histologic features (fibroblastic foci [FF], interstitial mononuclear cell infiltrate, established fibrosis, and intra-alveolar macrophages) using a semiquantitative scale of 0-6. An objective count of FF was also undertaken. Using weighted kappa coefficients, interobserver agreement between pathologists was moderate to good (0.56-0.76). Subjective and objective FF scores were strongly associated (R(S) = 0.88, < 0.00005). Mortality was independently linked to a high FF score, p = 0.006, and a low percent predicted carbon monoxide diffusing capacity (DL(CO)), p = 0.01. For pulmonary function, on univariate analysis, the strongest correlations were observed between increasing interstitial mononuclear cell infiltrate or FF scores and greater declines in forced vital capacity (FVC) or DL(CO) at 6 months. Multivariate models revealed that increasing FF scores were independently associated with greater declines in FVC and DL(CO) at both 6 and 12 months. Increasing interstitial mononuclear cell infiltrate scores were also independently linked to functional decline, but only at 6 months. These data suggest a reproducible method on biopsy for predicting rate of disease progression in patients with idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Year:  2002        PMID: 12119229     DOI: 10.1164/rccm.2109039

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  74 in total

1.  [Pulmonary fibrosis. Classification, diagnosis, therapy].

Authors:  U Costabel; J Guzman
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

2.  Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum.

Authors:  Carlyne D Cool; Steve D Groshong; Pradeep R Rai; Peter M Henson; J Scott Stewart; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

Review 3.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

4.  Peroxiredoxin II expression and its association with oxidative stress and cell proliferation in human idiopathic pulmonary fibrosis.

Authors:  Kirsi Vuorinen; Steffen Ohlmeier; Outi Leppäranta; Kaisa Salmenkivi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  J Histochem Cytochem       Date:  2008-07-07       Impact factor: 2.479

5.  tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis.

Authors:  Ling Chen; Jiwei Hou; Xiao Fu; Xiang Chen; Jiang Wu; Xiaodong Han
Journal:  Cell Cycle       Date:  2019-09-24       Impact factor: 4.534

6.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 7.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

Review 8.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

9.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

10.  Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha.

Authors:  Joana Câmara; Gabor Jarai
Journal:  Fibrogenesis Tissue Repair       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.